Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Closed
Phase 2
This trial is looking at different doses of ofatumumab in combination with chemotherapy for people with chronic lymphocytic leukaemia (CLL).
Recruitment start: 2 October 2012
Recruitment end: 31 March 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Hillmen
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Leeds Institute of Clinical Trials Research (University of Leeds)
Leeds Teaching Hospitals NHS Trust
Novartis
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKE/11/018.
Last reviewed: 17 Apr 2016
CRUK internal database number: 8279
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
